Check the acquisition promise
Read the store headline, screenshots and description. What problem is the app promising to solve?
Study the storefront ↗Skyscape Medpresso Inc · iOS
Explore the ad evidence, study the storefront, and build your next acquisition hypothesis.
01 / Creative research
Read the store headline, screenshots and description. What problem is the app promising to solve?
Study the storefront ↗Explore apps with direct store-link matches. Compare their hooks and formats without assuming the same approach works here.
Browse observed advertisers ↗Store rankings and revenue estimates describe market context. They do not establish ad spend, conversions or ROAS.
Review the market context ↗02 / Storefront & product
Study the product story and store experience behind the acquisition funnel.
03 / Market context
Keep revenue, downloads and store rankings separate from advertising performance.
Searching and tapping unasyn opens amifostine instead of unasyn. Thankfully this was caught. Edit: search “keppra” and the incorrect generic “lacosamide” comes up. This app is untrustworthy and can longer be used as reference.
The drug database updates with the actual publishers content. Peace of mind when dealing with newly approved FDA medications.
This app would be great if it wasn’t overpriced. $49.99 seems unreasonably high.
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. For nearly 50 years - #1...
| Name | Price | Type |
|---|---|---|
| Elsevier’s IV Med HBK 3/M Sub (Quarterly) | $25.99 | Quarterly |
| Elsevier’s IV Med HBK 6M Sub (6 Month) | $32.99 | Semi-Annual |
| 25% Off-Elsevier IVMed 1Y Sub (Annual) | $37.49 | Yearly |
| Elsevier IV Med HBK 1Y Sub off (Annual) | $39.99 | Yearly |
| 20% Off-Elsevier IVMed 1Y Sub (Annual) | $39.99 | Yearly |
| 15% Off-Elsevier IVMed 1Y Sub (Annual) | $42.49 | Yearly |
| Intravenous Medications 2022 | $49.99 | One-time |
| Elsevier’s IV Med HBK 1Y Sub (Annual) | $49.99 | Yearly |